Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rick Papandrea

Orthopaedic Surgery Pewaukee, WI Medical Doctor

NPI 1952383531 CMS profile 732489

N15w28300 Golf Rd, Pewaukee, WI 53072

Open in the dashboard

General payments

$271,483

171 records reported · program years 2019–2025

Research payments

$277,220

Paid to them · 13 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$475,605 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Rick Papandrea of Pewaukee, WI is reported in the CMS Open Payments database as having received $271,483 across 171 general payments and $277,220 in research payments paid to them. Separately, studies naming them as principal investigator received $475,605 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $34,885 17
2024 General $19,122 20
2024 Research $32,420 1
2023 General $26,008 23
2022 General $61,996 42
2022 Research $123,000 5
2021 General $89,812 27
2020 General $20,392 19
2020 Research $72,685 4
2019 General $19,269 23
2019 Research $49,115 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rick Papandrea
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Rick Papandrea were reported at $34,885. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Rick Papandrea Orthopaedic Surgery median Middle half National median
2019 $19,269 $644 $140–$2,844 $163
2020 $20,392 $312 $75–$1,860 $114
2021 $89,812 $520 $117–$2,495 $132
2022 $61,996 $598 $128–$2,731 $149
2023 $26,008 $461 $128–$2,264 $160
2024 $19,122 $497 $134–$2,475 $164
2025 $34,885 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Exactech, Inc. $188,804 142 payments
  2. Apria Healthcare LLC $61,702 13 payments
  3. Medical Device Business Services, Inc. $11,785 4 payments
  4. DePuy Synthes Sales Inc. $5,865 4 payments
  5. Checkpoint Surgical, Inc $2,504 1 payment
  6. Skeletal Dynamics Inc $493 2 payments
  7. Stryker Corporation $161 1 payment
  8. Wright Medical Technology, Inc. $111 1 payment
  9. Flexion Therapeutics, Inc. $21 1 payment
  10. AxoGen $19 1 payment
  11. Other $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $171,105 80 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $62,002 14 payments
  3. Travel and Lodging $29,766 34 payments
  4. Food and Beverage $6,106 42 payments
  5. Charitable Contribution $2,504 1 payment
Products named General payments · program years 2019–2025
  1. Equinoxe Orthopaedic $95,109 74 payments
  2. EQUINOXE Orthopaedic $55,083 44 payments
  3. EQUINOXE Orthopaedic $17,483 11 payments
  4. EQUINOXE PHX SYSTEM $15,163 3 payments
  5. LCP $14,040 4 payments
  6. NA Trauma $14,040 4 payments
  7. NA Trauma $14,040 4 payments
  8. EXACTECHGPS $3,135 4 payments
  9. LCP PLATES & SCREWS $2,925 1 payment
  10. INSTRUMENTS $2,925 1 payment
  11. Other $8,604 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Exactech, Inc. $277,220 13 payments

Billing to Medicare

Part B · data year 2024 · 73 billing codes

Paid by Medicare

$151,014

Of which drugs: $4,031

Medicare patients

318

Average age 73

Services billed

2,450

179 women, 139 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 73%
Ischemic heart disease 28%
Chronic kidney disease 21%
Depression 21%
Diabetes 18%
Osteoporosis 16%
Heart failure 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 53 236 $1,143
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 92 513 $400

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

184 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record